Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Open accessThe DOI matches its Crossref record; 235 of the 236 references it cites were found in a registry or an index; 50 of the 187 sources its claims cite were checked for support.
Abstract
Organisms are continually exposed to exogenous and endogenous sources of reactive oxygen species (ROS) and other oxidants that have both beneficial and deleterious effects on the cell. ROS have important roles in a wide range of physiological processes; however, high ROS levels are associated with oxidative stress and disease progression. Oxidative stress has been implicated in nearly all major human diseases, from neurogenerative diseases and neuropsychiatric disorders to cardiovascular disease, diabetes, and cancer. Antioxidant defence systems have evolved as a means of protection against oxidative stress, with the transcription factor Nrf2 as the key regulator. Nrf2 is responsible for regulating an extensive panel of antioxidant enzymes involved in the detoxification and elimination of oxidative stress and has been extensively studied in the disease contexts. This review aims to provide the reader with a general overview of oxidative stress and Nrf2, including basic mechanisms of Nrf2 activation and regulation, and implications in various major human diseases.
Overview
CoChat Summary
TL;DR
This narrative review summarizes oxidative stress and the Keap1-Nrf2 antioxidant pathway, covering Nrf2 activation, regulation, and interacting proteins. It highlights Nrf2 as the master regulator of antioxidant and phase II enzymes, with protective roles in many diseases but also a harmful “dark side” in cancer.
Key findings
- Nrf2 is the key transcriptional regulator of ARE-driven antioxidant and phase II enzyme genes; under basal conditions Nrf2 has a short half-life of only 10–30 min, and Keap1 mediates its Cul3-dependent ubiquitination and proteasomal degradation.
- Keap1 senses oxidative stress through reactive cysteines: human Keap1 contains 27 cysteine residues, about 4% of its amino acid content versus a 2% average for the human proteome; Cys273 and Cys288 are required for sensing oxidative stress under basal and stress conditions, while Cys151 may be required only during oxidative stress.
- The Keap1-Nrf2 two-site recognition model depends on the high-affinity ETGE motif and low-affinity DLG motif; the ETGE motif has a binding affinity two orders of magnitude higher than the DLG motif, making DLG an “on/off switch” for Nrf2 ubiquitination.
- Nrf2 is implicated in major human diseases: reduced nuclear Nrf2 is observed in Alzheimer’s disease brain regions; Nrf2 pathway alterations occur in 34% of squamous cell lung cancer specimens; and Nrf2 hyperactivation can promote chemoresistance to drugs such as cisplatin, 5-fluorouracil, docetaxel, and bortezomib.
Methods
- Design: narrative review providing a general overview of oxidative stress, Nrf2 mechanisms, and implications in human disease.
- Data or sample: no primary experimental data or human/animal sample; the paper synthesizes published literature and cites prior studies, reviews, and model-organism findings.
- Main analysis: descriptive synthesis of ROS/RNS biology, antioxidant enzymes, ARE regulation, canonical and non-canonical Keap1-Nrf2 regulation, Nrf2-interacting proteins, and disease associations including neurodegenerative disease, neuropsychiatric disorders, cardiovascular disease, diabetes, cancer, inflammation, and aging.
Limitations
- The paper does not state formal limitations; it describes the review as a “general overview” and notes that several topics are “briefly discussed” or “beyond the scope of this review.”
- Evident from the text: as a narrative review, it lacks a systematic search strategy, predefined inclusion criteria, or quantitative synthesis, and it presents no primary data.
- Evident from the text: disease sections are broad and selective rather than exhaustive, and the authors repeatedly refer readers to other reviews for more detailed discussion.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
23 Valid · 5 Not valid · 72 Not checked · 17 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“WTX is also involved in oxidative stress regulation through its competitive binding to the Keap1, which inhibits Nrf2 ubiquitination [84].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.7. Keap1-Interacting Proteins
What the sources say
- Disputedcites [84] Copple, 2010, Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The Discussion attributes competitive binding to Keap1 and reduced Nrf2 ubiquitination to SQSTM1 (p62), not WTX. The paper’s stated mechanism therefore identifies a different protein from the one in the citing sentence; no page number is available in our copy. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Chronic oxidative stress and the resultant oxidative damage have been implicated in many human diseases including cardiovascular disease, neurodegenerative diseases, diabetes, cancer, and the aging process [18,19,20,21,22].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 1. Oxidative Stress > 1.2. Oxidative Stress
What the sources say
- Partly supportedcites [18] Reuter, 2010, Oxidative stress, inflammation, and cancer: How are they linked?, Free Radic. Biol. Med. sourceExperimental — accuracy not yet measured
The Introduction links sustained oxidative stress and cellular damage to cancer, and describes increased oxidative stress and accumulated molecular damage in aging. The passages from the body of our copy do not substantiate the additional claims about cardiovascular disease, neurodegenerative diseases, or diabetes; those conditions appear in the retrieved reference titles. (LLM, conf=0.84)
- Partly supportedcites [19] Alfadda, 2012, Reactive Oxygen Species in Health and Disease, J. Biomed. Biotechnol. sourceExperimental — accuracy not yet measured
The Introduction (section 1; page unavailable) links ROS to cancer, diabetes, cardiovascular disease, and aging, and section 5.3 links oxidative stress to diabetic complications. The passages found do not establish the claimed link to neurodegenerative diseases or characterize the whole disease list specifically as consequences of chronic oxidative stress and resultant damage. (LLM, conf=0.84)
- Partly supportedcites [20] Asmat, 2016, Diabetes mellitus and oxidative stress—A concise review, Saudi Pharm. J. sourceExperimental — accuracy not yet measured
The 'Oxidative stress and antioxidants' section links oxidative damage to a wide variety of diseases, notably cancer and heart disease. 'Oxidative stress and diabetic complications' also links oxidative stress to diabetes and coronary artery disease. Our copy does not establish the claimed link to neurodegenerative diseases or aging; it mentions aging as a possible factor contributing to oxidative stress, not as a resulting condition. No page numbers are available in our copy. (LLM, conf=0.86)
- Supportedcites [21] Liguori, 2018, Oxidative stress, aging, and diseases, Clin. Interv. Aging source
The sections on cardiovascular disease, diabetes, cognitive impairment and dementia, and cancer each link oxidative stress or oxidative damage to the named conditions. The section on the theory of aging describes accumulated oxidative damage as a proposed explanation for age-related functional loss. Page numbers are not available in our copy. (LLM, conf=0.92)
- Not checked yetcites [22] Barnham, 2004, Neurodegenerative diseases and oxidative stress, Nat. Rev. Drug Discov. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Nrf2 regulates the expression of a multitude of antioxidant and phase II enzyme genes and is negatively regulated by Kelch-like ECH-associated protein (Keap1) [49], a substrate adaptor protein that binds to Nrf2 in the cytosol to facilitate its polyubiquitination by the Cullin 3 (Cul3) E3 ubiquitin ligase for proteasomal degradation [50,51,52].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.1. Keap1-Nrf2 Signalling
What the sources say
- Supportedcites [49] Itoh, 1999, Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, Genes Dev. source
The Abstract states that Keap1 suppresses Nrf2 transcriptional activity by binding its amino-terminal regulatory domain. The Discussion also describes Nrf2 as sequestered in the cytoplasm through its association with Keap1. This source is cited for negative regulation by Keap1; the later Cul3, polyubiquitination, and degradation mechanism is attached to citations [50–52], not this one. (LLM, conf=0.94)
- Supportedcites [50] Nguyen, 2003, Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome, J. Biol. Chem. source
Citation [49] is attached to the claim that Keap1 negatively regulates Nrf2. The paper describes Keap1 retaining Nrf2 in the cytoplasm and says that their dissociation allows Nrf2 to enter the nucleus (introductory passage and Discussion). The subsequent Cul3 polyubiquitination mechanism is attached to citations [50–52], not this source. (LLM, conf=0.92)
- Supportedcites [51] Kobayashi, 2004, Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2, Mol. Cell. Biol. source
The Abstract states that Keap1 retains Nrf2 in the cytoplasm, binds it directly, and acts as an adaptor for Cul3-based E3 ligase in its proteasomal degradation. The Results report ubiquitin-chain conjugation and show that Nrf2 ubiquitination depends on its interaction with Keap1. (LLM, conf=0.93)
- Not checked yetcites [52] McMahon, 2003, Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression, J. Biol. Chem. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Oxidative damage has been implicated in all major neurodegenerative diseases including Alzheimer’s disease (AD) [108,109], Parkinson’s disease (PD) [110,111], Huntington’s disease (HD) [112,113], amyotrophic lateral sclerosis (ALS) [114], and multiple sclerosis (MS) [115].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 3. Nrf2 in Human Disease > 3.1. Neurodegenerative Disease
What the sources say
- Supportedcites [108] Smith, 2000, Oxidative stress in Alzheimer’s disease, Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. source
This source is cited for the Alzheimer’s disease portion of the sentence, not for the other listed diseases. Section 2, “Oxidative damage,” describes oxidative damage in AD, and the Conclusion states that oxidative stress plays an important role in AD pathogenesis. (LLM, conf=0.94)
- Supportedcites [109] Cioffi, 2019, Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease, J. Alzheimer’s Dis. JAD source
The sentence assigns separate citations to each disease; this source supports the Alzheimer’s disease portion. The Introduction reports early hallmarks of oxidative stress in AD, and “Oxidative Damage to Biomacromolecules in Alzheimer’s Disease” describes oxidative damage in AD brain tissue. The source need not support the other diseases, which have their own citations. (LLM, conf=0.92)
- Not checked yetcites [110] Dias, 2013, The Role of Oxidative Stress in Parkinson’s Disease, J. Park. Dis.
- Supportedcites [111] Blesa, 2015, Oxidative stress and Parkinson’s disease, Front. Neuroanat. source
The citation is attached to the Parkinson’s disease portion of the sentence, not the list of other diseases. The Introduction states that Parkinson’s disease is related to excess reactive oxygen species and that oxidative stress is thought to underlie cellular dysfunction and death in PD. (LLM, conf=0.94)
- Not checked yetcites [112] Browne, 1999, Oxidative stress in Huntington’s disease, Brain Pathol. source
- Supportedcites [113] Kumar, 2016, Oxidative Stress and Huntington’s Disease: The Good, the Bad, and the Ugly, J. Huntingt. Dis. source
The citation to this source is attached to Huntington’s disease, not to the other diseases in the sentence. The section “Is Oxidative Stress a Cause or a Consequence in HD Pathology?” reports increased oxidative damage in postmortem HD brains and describes oxidative stress as implicated in HD pathogenesis. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Nrf2 association requires the homodimerization of Keap1 [74].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.4. Keap1-Dependent Nrf2 Regulation
What the sources say
- Supportedcites [74] Zipper, 2002, The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm, J. Biol. Chem. source
The Discussion states that the integrity of the Keap1–Nrf2 complex depends on Keap1 dimerization and calls the BTB/POZ dimerization function a prerequisite for Nrf2 binding. The Results (Fig. 3B) also report reduced Nrf2 association with a Keap1 mutant deficient in homodimerization. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
67 more claims · 13 with their cited sources checked
Create a free account to see all 117 claims and to verify the 137 references still open.
- It may state two separate claims as one. 42
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The transcription factor Nrf2 acts as a central regulator of the host’s primary antioxidant defense system [73,74] and determines cellular fate during envenomation.”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 1. Oxidative Stress > 1.1. Reactive Oxygen Species
“superoxide radicals which are readily detoxified to hydrogen peroxide (H2O2) by antioxidant enzymes such as catalase and glutathione peroxidase.”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 1. Oxidative Stress > 1.3. Antioxidant Response Enzymes
“SODs are responsible for the dismutation (simultaneous oxidation and reduction) and breakdown of superoxide radicals into molecular oxygen and hydrogen peroxide”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.7. Keap1-Interacting Proteins
“In 2010, five independent groups discovered the interaction between p62 and Keap1 [77,78,79,80,81].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > References
“78. Baird L. Yamamoto M. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway Mol. Cell. Biol. 2020 40 e00099-20”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.7. Keap1-Interacting Proteins
“WTX is also involved in oxidative stress regulation through its competitive binding to the Keap1, which inhibits Nrf2 ubiquitination [84].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > References
“84. Copple I.M. Lister A. Obeng A.D. Kitteringham N.R. Jenkins R.E. Layfield R. Foster B.J. Goldring C.E. Park B.K. Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway”
Citations
Cites
1 retracted
Items 201–235 of 235
Xu, P., Liu, Q., Xie, Y., Shi, X., Li, Y., Peng, M., Guo, H., Sun, R., Li, J., Hong, Y., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.06.012 · Cited by 100 · cited 4×
“The BRCT domain of BRCA1 interacts with the ETGE motif in the Neh2 domain of Nrf2, which inhibits Keap1-mediated ubiquitination and increases the response to oxidative stress [82,83].”
BackgroundInfluentialRahman, M. M., Sykiotis, G. P., Nishimura, M., Bodmer, R., & Bohmann, D. (2013) · Aging Cell · doi:10.1111/acel.12078 · Cited by 100
A PGAM5–KEAP1–Nrf2 complex is required for stress-induced mitochondrial retrograde trafficking
O'Mealey, G. B., Plafker, K. S., Berry, W. L., Janknecht, R., Chan, J. Y., & Plafker, S. M. (2017) · Journal of Cell Science · doi:10.1242/jcs.203216 · Cited by 99 · cited 1×
“Interestingly, this results in the stress-induced Keap1-mediated ubiquitination and degradation of not Nrf2, but of mitochondrial Rho GTPase 2 (Miro2), a mitochondrial GTPase involved in mitochondrial motility [104].”
BackgroundIchikawa, T., Li, J., Meyer, C. J., Janicki, J. S., Hannink, M., & Cui, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008391 · Cited by 99
Essential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future Perspective
Hashimoto, K. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01182 · Cited by 98 · cited 1×
“For additional information of Nrf2 in neuropsychiatric disorders, refer to the reviews by Hashimoto (2018) [132] and Morris et al. (2021) [141].”
BackgroundSun, Z., Wu, T., Zhao, F., Lau, A., Birch, C. M., & Zhang, D. D. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05036-11 · Cited by 97 · cited 2×
“Keap1 p62/SQSTM1 349DPSTGE354 (p62) Kelch +; Keap1 inhibition [84–88] ProTα/PTMA 38NANEENGE45 (ProTα) Kelch +; Keap1 inhibition [89] DPP3 480ETGE483 (DPP3) Kelch +; Keap1 inhibition [90] WTX 286SPETGE291 (WTX) Kelch +; Keap1 inhibition [91] PALB2/FANCN 91ETGE94 (PALB2) BTB +; Keap1 inhibition [92] KPNA6/Importin α7 AR…”
BackgroundTargeting NRF2 to treat cancer
Sivinski, J., Zhang, D. D., & Chapman, E. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.003 · Cited by 96
Hammond, P. W., Alpin, J., Rise, C. E., Wright, M., & Kreider, B. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011641200 · Cited by 93 · cited 2×
“WTX is a tumour suppressor and regulator in the canonical Wnt signalling pathway, which mediates critical aspects of embryonic development by promoting the ubiquitination and degradation of β-catenin [101,102].”
BackgroundRushworth, S. A., Bowles, K. M., & MacEwan, D. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3018 · Cited by 92
KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma
Li, Q. K., Singh, A., Biswal, S., Askin, F., & Gabrielson, E. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2010.172 · Cited by 90
The oxidative damage theory of aging
Lin, M. T., & Flint Beal, M. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00007-0 · Cited by 89
Hartikainen, J. M., Tengström, M., Kosma, V.-M., Kinnula, V. L., Mannermaa, A., & Soini, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1474 · Cited by 89
Itabe, H. (2012) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-00020r1 · Cited by 87
Increased ROS production and DNA damage in monocytes are biomarkers of aging and atherosclerosis
Jacinto, T. A., Meireles, G. S., Dias, A. T., Aires, R., Porto, M. L., Gava, A. L., Vasquez, E. C., Pereira, T. M. C., Campagnaro, B. P., & Meyrelles, S. S. (2018) · Biological Research · doi:10.1186/s40659-018-0182-7 · Cited by 86
Cuadrado, A. (2022) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052220-103416 · Cited by 86 · cited 1×
“The current status of Nrf2 in neurodegenerative disease is comprehensively reviewed by Zgorzynska et al. (2021) [123], Cuadrado (2022) [124], George et al. (2022) [125].”
BackgroundLee, H., Kim, D. W., Jung, K.-Y., Park, I., Park, M., Kim, M.-S., Woo, S., Rhee, C., Yoo, H., Lee, S., et al. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.13.6.883 · Cited by 85
Zhuang, C., Wu, Z., Xing, C., & Miao, Z. (2017) · MedChemComm · doi:10.1039/c6md00500d · Cited by 84
Luceri, C., Bigagli, E., Femia, A. P., Caderni, G., Giovannelli, L., & Lodovici, M. (2018) · Toxicology Reports · doi:10.1016/j.toxrep.2017.12.017 · Cited by 79
Hagmann, H., Kuczkowski, A., Ruehl, M., Lamkemeyer, T., Brodesser, S., Horke, S., Dryer, S. E., Schermer, B., Benzing, T. R., & Brinkkoetter, P. T. (2014) · The FASEB Journal · doi:10.1096/fj.13-240309 · Cited by 79 · cited 1×
“Additionally, PON2 interacts with the electron transport chain in the inner mitochondrial membrane to significantly reduce the production of superoxide ions [35].”
BackgroundMutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer
Takahashi, T., Sonobe, M., Menju, T., Nakayama, E., Mino, N., Iwakiri, S., Nagai, S., Sato, K., Miyahara, R., Okubo, K., et al. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21520 · Cited by 78
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer
Kim, E. H., Jang, H., Shin, D., Baek, S. H., & Roh, J.-L. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1284-8 · Cited by 77
Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry
Morris, G., Walker, A. J., Walder, K., Berk, M., Marx, W., Carvalho, A. F., Maes, M., & Puri, B. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02212-w · Cited by 72
The Role of NRF2 in Obesity-Associated Cardiovascular Risk Factors
Gutiérrez‐Cuevas, J., Galicia‐Moreno, M., Monroy-Ramírez, H. C., Sandoval-Rodriguez, A. S., Garcia-Bañuelos, J. J., Santos, A., & Armendáriz‐Borunda, J. (2022) · Antioxidants · doi:10.3390/antiox11020235 · Cited by 71
Szczesny-Malysiak, E., Stojak, M., Campagna, R., Grosicki, M., Jamrozik, M., Kaczara, P., & Chlopicki, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4678252 · Cited by 70
Santhanam, A. V. R., d’Uscio, L. V., Smith, L. A., & Katusic, Z. S. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07872.x · Cited by 64
Cao, Z., Zhu, H., Zhang, L., Zhao, X., Zweier, J. L., & Li, Y. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100809 · Cited by 56
Multifaceted Roles of the KEAP1–NRF2 System in Cancer and Inflammatory Disease Milieu
Panda, H., Wen, H., Suzuki, M., & Yamamoto, M. P. (2022) · Antioxidants · doi:10.3390/antiox11030538 · Cited by 47 · cited 1×
“For further reading on the role of Nrf2 in cancer, refer to Taguchi et al. (2017) [177], Rojo de la Vega et al. (2018) [176], and Panda et al. (2022) [186].”
BackgroundManandhar, S., Choi, B.-H., Jung, K.-A., Ryoo, I.-G., Song, M., Kang, S. J., Choi, H.-G., Kim, J.-A., Park, P.-H., & Kwak, M.-K. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.031 · Cited by 45
Bladder Cancer Chemosensitivity Is Affected by Paraoxonase-2 Expression
Fumarola, S., Cecati, M., Sartini, D., Ferretti, G., Milanese, G., Galosi, A. B., Pozzi, V., Campagna, R., Morresi, C., Emanuelli, M., et al. (2020) · Antioxidants · doi:10.3390/antiox9020175 · Cited by 37 · cited 1×
“The importance of PON2 as an antioxidant is demonstrated by work showing that the downregulation of PON2 significantly sensitizes cells to oxidative stress [36].”
BackgroundNrf2 is associated with the regulation of basal transcription activity of the BRCA1 gene
Wang, Q., Li, J., Yang, X., Sun, H., Gao, S., Zhu, H., Wu, J., & Jin, W. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt001 · Cited by 35 · cited 2×
“Dipeptidyl-peptidase 3 (DPP3) participates in the cleavage and degradation of bioactive peptides generated by the proteasome during protein degradation [98,99].”
BackgroundDietary phytochemicals targeting Nrf2 for chemoprevention in breast cancer
Wang, P., Long, F., Lin, H., & Wang, T. (2022) · Food & Function · doi:10.1039/d2fo00186a · Cited by 28
Nrf2 sensitizes prostate cancer cells to radiation via decreasing basal ROS levels
Liu, M., Yao, X., Li, W., Geng, J., Yan, Y., Che, J., Xu, Y., & Zheng, J. (2015) · BioFactors · doi:10.1002/biof.1200 · Cited by 27
Cleasby, A., Yon, J., Day, P. J., Richardson, C., Tickle, I. J., Williams, P. A., Callahan, J. F., Carr, R., Concha, N., Kerns, J. K., et al. (2014) · Worldwide Protein Data Bank · doi:10.2210/pdb4cxi/pdb · Cited by 21
Nrf2-Mediated Dichotomy in the Vascular System: Mechanistic and Therapeutic Perspective
Wu, W., Hendrix, A., Nair, S., & Cui, T. (2022) · Cells · doi:10.3390/cells11193042 · Cited by 20 · cited 1×
“For additional readings on this topic, refer to da Costa et al. (2019) [152], Gutiérrez [153]-Cuevas et al. (2022), and Wu et al. (2022) [154].”
BackgroundThe complex role of NRF2 in cancer: A genomic view
Praslicka, B. J., Kerins, M. J., & Ooi, A. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.09.003 · Cited by 14
Cited by
Interplay of oxidative stress, cellular communication and signaling pathways in cancer
Iqbal, M. J., Kabeer, A., Abbas, Z., Siddiqui, H. A., Calina, D., Sharifi-Rad, J., & Cho, W. C. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01398-5 · Cited by 418
“3) [7, 36].”
BackgroundRedox Imbalance in Inflammation: The Interplay of Oxidative and Reductive Stress
Bellanti, F., Coda, A. R. D., Trecca, M. I., Lo Buglio, A., Serviddio, G., & Vendemiale, G. (2025) · Antioxidants · doi:10.3390/antiox14060656 · Cited by 177
“Nrf2 is normally bound to Keap1, which facilitates its ubiquitination and degradation, but OS modifies critical cysteine residues on Keap1, leading to the stabilization and nuclear translocation of Nrf2 [28,29].”
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers
Liang, X., Weng, J., You, Z., Wang, Y., Wen, J., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02375-x · Cited by 219
Fornari Laurindo, L., Aparecido Dias, J., Cressoni Araújo, A., Torres Pomini, K., Machado Galhardi, C., Rucco Penteado Detregiachi, C., Santos de Argollo Haber, L., Donizeti Roque, D., Dib Bechara, M., Vialogo Marques de Castro, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305933 · Cited by 144
Selvaraj, N. R., Nandan, D., Nair, B. J. B., Nair, V. A., Venugopal, P., & Aradhya, R. (2025) · Cells · doi:10.3390/cells14070511 · Cited by 176
“While generally considered protective, elevated Nrf2 activity may, in some cases, promote tumor growth and chemoresistance [289].”
Metadata
- Authors
- Ngo, V., & Duennwald, M. L.
- Affiliations
- Western University (CA)
- Corresponding author
- Duennwald, Martin L.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2022-11-27
- Volume
- 11
- Issue
- 12
- Pages
- 2345
- ISSN
- 2076-3921 (ISSN-L)
- PMC
- PMC9774434
- OpenAlex
- W4310211651
- Semantic Scholar
- ae6aa01efc202b0f3f701cefd15f11f215aa3aa5
- Cited by
- 1,130
- References
- 236
- Citations by year
- 2026: 415 · 2025: 448 · 2024: 200 · 2023: 67
- FWCI
- 18.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antioxidants (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- TBCRU (n/a)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Nrf2, oxidative stress, reactive oxygen species, antioxidant defense, antioxidant enzymes, Nrf2 activation, neurodegenerative diseases, cardiovascular disease, diabetes mellitus, cancer, detoxification
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.